Trials / Completed
CompletedNCT01789918
TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation (ACHIEVE)
TrAnsCatHeter Intravascular Ultrasound Energy deliVery for rEnal Denervation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (actual)
- Sponsor
- ReCor Medical, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The ACHIEVE study is a single-arm, open-label, prospective, post-market follow-up study to include up to one hundred (100) eligible patients as defined within the clinical investigational plan, with a twelve month follow-up period. The ACHIEVE study was originally designed in accordance with the 2007 ESH ESC guidelines for resistant hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | PARADISE percutaneous renal denervation | Intravascular ultrasound emission |
Timeline
- Start date
- 2013-01-09
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2013-02-12
- Last updated
- 2018-07-06
Locations
8 sites across 3 countries: Germany, Netherlands, Sweden
Source: ClinicalTrials.gov record NCT01789918. Inclusion in this directory is not an endorsement.